Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanyuan Kong

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|October 27, 2021
Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatmentYue Tang, Yuanyuan Kong
Psychiatry Research|May 21, 2010
Access to farming pesticides and risk for suicide in Chinese rural young peopleYuanyuan Kong, Jie Zhang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Incorrect calculation and inappropriate interpretation: accuracy of international guidelines for identifying significant fibrosis in e antigen-negative chronic hepatitis BYuanyuan Kong, Xiaoqing Liu, Jidong Jia
Revista Espanola De Enfermedades Digestivas|October 7, 2015
Efficacy and safety of simeprevir in combination with peginterferon and ribavirin for patients with hepatitis C genotype 1 infection: a meta-analysis of randomized trialsXianghua Cui, Yuanyuan Kong, Jidong Jia
Hepatology International|February 25, 2016
Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common senseYuanyuan Kong, Hong You, Jidong Jia
Oncology Letters|June 17, 2026
Warm autoimmune hemolytic anemia following definitive chemoradiotherapy for cervical cancer: A case reportYuanyuan Kong, Liangxue Zhu, Yuelan Xiao
JAMA Oncology|April 26, 2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis BYuanyuan Kong, Jidong Jia, Hwai-I Yang
Alimentary Pharmacology & Therapeutics|November 21, 2023
Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels-Authors' replyShun Li, Lichen Shi, Jidong Jia, et al.
International Journal of General Medicine|June 30, 2025
The Prognostic and Early Efficacy Prediction Value of Baseline C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index in Advanced Pancreatic CancerLiangxue Zhu, Yuanyuan Kong, Yajun Xing, et al.
Clinical and Molecular Hepatology|July 22, 2024
Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients"Xiaoqian Xu, Hong You, Jidong Jia, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|October 27, 2021
Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatmentYue Tang, Yuanyuan Kong
Psychiatry Research|May 21, 2010
Access to farming pesticides and risk for suicide in Chinese rural young peopleYuanyuan Kong, Jie Zhang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Incorrect calculation and inappropriate interpretation: accuracy of international guidelines for identifying significant fibrosis in e antigen-negative chronic hepatitis BYuanyuan Kong, Xiaoqing Liu, Jidong Jia
Revista Espanola De Enfermedades Digestivas|October 7, 2015
Efficacy and safety of simeprevir in combination with peginterferon and ribavirin for patients with hepatitis C genotype 1 infection: a meta-analysis of randomized trialsXianghua Cui, Yuanyuan Kong, Jidong Jia
Hepatology International|February 25, 2016
Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common senseYuanyuan Kong, Hong You, Jidong Jia
Oncology Letters|June 17, 2026
Warm autoimmune hemolytic anemia following definitive chemoradiotherapy for cervical cancer: A case reportYuanyuan Kong, Liangxue Zhu, Yuelan Xiao
JAMA Oncology|April 26, 2019
Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis BYuanyuan Kong, Jidong Jia, Hwai-I Yang
Alimentary Pharmacology & Therapeutics|November 21, 2023
Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels-Authors' replyShun Li, Lichen Shi, Jidong Jia, et al.
International Journal of General Medicine|June 30, 2025
The Prognostic and Early Efficacy Prediction Value of Baseline C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index in Advanced Pancreatic CancerLiangxue Zhu, Yuanyuan Kong, Yajun Xing, et al.
Clinical and Molecular Hepatology|July 22, 2024
Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients"Xiaoqian Xu, Hong You, Jidong Jia, et al.
Pageof 18